| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2285 |
| Trial ID | NCT04226989 |
| Disease | Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CT-RD06 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A Study of CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy |
| Year | 2020 |
| Country | China |
| Company sponsor | He Huang |
| Other ID(s) | BHCT-CT-RD06-03 |
| Cohort 1 | |||||||
|
|||||||